MyFinsight
Home
Blog
About
Contact
Download
Download image
Issuance of shares,
options exercise
$1,985K
Net cash provided by
/ (used in)...
$1,824K
Canceled cashflow
$161K
(decrease) / increase in
cash and cash...
-$4,687K
Canceled cashflow
$1,824K
Stock-based compensation -
employees
$4,511K
Accounts payable
$2,625K
Prepaid expenses
-$1,681K
Accrued liabilities
$273K
Other assets
-$85K
Amortization of norgine asset
$77K
Allowance for credit
losses
$67K
Amortization of debt discount
$38K
Loss on securities
$2K
Cash paid for taxes on
restricted share release
$161K
Net cash (used in) /
provided by operating...
-$6,511K
Canceled cashflow
$9,359K
Accounts receivable
$8,982K
Net (loss)/income
-$4,954K
Inventory
$1,417K
Inventory reserve
-$517K
Back
Back
Cash Flow
source: myfinsight.com
FENNEC PHARMACEUTICALS INC. (FENCF)
FENNEC PHARMACEUTICALS INC. (FENCF)